109 results
Page 3 of 6
6-K
EX-99.1
axog 5tk6mne
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
1c6uk4 ee6npqwt3oo
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.1
8hmo6e
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.2
br5k7lr5h8i0hxy
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
EX-4.1
xxm4 3olmf3utmdm
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.1
59tl2 uezxt3nb6j
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.2
p9vk11 p5
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.1
vdgzlqgi xx9y
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
9rpokuy405sd 4z7s
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
r8r2wswgi0rltz1v1
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.2
rbna92w3
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
bovditof2r ky50
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
dyqvl3u
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
0yu1f
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
lf95zr 1t84yq6krsp
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
d9jdqv
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
o2u9kn
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
xh7k2
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
a6cldx
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
EX-99.1
vjcjqf6jf3hm6kje4ge
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am